KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Free Cash Flow: 2010-2024

Historic Free Cash Flow for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to $1.2 million.

  • TherapeuticsMD's Free Cash Flow rose 1507.04% to $999,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 155.06%. This contributed to the annual value of $1.2 million for FY2024, which is 105.07% up from last year.
  • As of FY2024, TherapeuticsMD's Free Cash Flow stood at $1.2 million, which was up 105.07% from -$23.1 million recorded in FY2023.
  • In the past 5 years, TherapeuticsMD's Free Cash Flow registered a high of $9.4 million during FY2022, and its lowest value of -$159.7 million during FY2020.
  • Moreover, its 3-year median value for Free Cash Flow was $1.2 million (2024), whereas its average is -$4.2 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first soared by 116.96% in 2022, then plummeted by 346.62% in 2023.
  • Yearly analysis of 5 years shows TherapeuticsMD's Free Cash Flow stood at -$159.7 million in 2020, then skyrocketed by 65.45% to -$55.2 million in 2021, then skyrocketed by 116.96% to $9.4 million in 2022, then crashed by 346.62% to -$23.1 million in 2023, then skyrocketed by 105.07% to $1.2 million in 2024.